Global Life Science Industry Leader
Life Sciences
EY Global Life Science
Belarus
She developed a non audit pharmaceutical and life sciences strategy and opened up our Ernst & Young relationships with GlaxoSmithKline and AstraZeneca .She also led transactions in the health sciences and technology sector particularly in the US and Europe including refinancing of capital structures, acquisitions, disposals and post merger integration support.She worked in Ernst and Young Company from November 1998 to December 2007.
Bussiness Development, Transaction Services, R&D operations.